kidney injury

Guard argues new data render primary endpoint miss 'irrelevant,' tripling share price
Fierce Biotech
Tue, 09/19/23 - 10:41 am
Guard Therapeutics
kidney injury
clinical trials
RMC-035
Alloksys fails to stop kidney injury in heart surgery patients, but subgroup spurs phase 3 plans
Fierce Biotech
Thu, 08/24/23 - 10:18 am
Alloksys
kidney injury
RESCAP
AM-Pharma, once a Pfizer takeover target, flunks phase 3 kidney injury trial
Fierce Biotech
Thu, 10/20/22 - 10:35 am
AM-Pharma
clinical trials
kidney injury
Pfizer
Angion’s kidney transplant dream dies
EP Vantage
Wed, 10/27/21 - 10:52 am
Angion Biomedica
ANG-3777
kidney injury
Vifor Pharma